Home > > > Report Detail

Global Preimplantation Genetics Diagnosis (PGD) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 11-Oct-2022
No. of pages: 111
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Preimplantation Genetics Diagnosis (PGD) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Preimplantation Genetics Diagnosis (PGD) market. Further, it explains the major drivers and regional dynamics of the global Preimplantation Genetics Diagnosis (PGD) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott Laboratories

- Natera, Inc

- PerkinElmer

- Illumina

- F. Hoffmann-La Roche

- Thermo Fisher Scientific

- Laboratory Corporation of America Holdings

- Agilent Technologies

- Quest Diagnostics Incorporated

- Cooper Surgical

- Beijing Genomics Institute (BGI)

- Genea Limited

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Preimplantation Genetics Diagnosis (PGD) Segment by Type

- Gender Selection

- Chromosomal Abnormalities

- Single Gene Disorders

- HLA Typing

- Aneuploidy

- X-Linked Diseases

- Others

Preimplantation Genetics Diagnosis (PGD) Segment by Application

- Hospitals

- Clinics

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Preimplantation Genetics Diagnosis (PGD) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Preimplantation Genetics Diagnosis (PGD) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Preimplantation Genetics Diagnosis (PGD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Preimplantation Genetics Diagnosis (PGD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Preimplantation Genetics Diagnosis (PGD) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Preimplantation Genetics Diagnosis (PGD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Preimplantation Genetics Diagnosis (PGD) revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories, Natera, Inc, PerkinElmer, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Agilent Technologies and Quest Diagnostics Incorporated, etc.

Global Preimplantation Genetics Diagnosis (PGD) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Gender Selection
1.2.3 Chromosomal Abnormalities
1.2.4 Single Gene Disorders
1.2.5 HLA Typing
1.2.6 Aneuploidy
1.2.7 X-Linked Diseases
1.2.8 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size (2017-2028)
2.2 Preimplantation Genetics Diagnosis (PGD) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2017-2022)
2.4 Global Preimplantation Genetics Diagnosis (PGD) Market Size Forecast by Region (2023-2028)
2.5 Global Top Preimplantation Genetics Diagnosis (PGD) Countries Ranking by Market Size
3 Preimplantation Genetics Diagnosis (PGD) Competitive by Company
3.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players
3.1.1 Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players (2017-2022)
3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players (2017-2022)
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2021
3.5 Global Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Revenue by Type (2017-2022)
4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Revenue by Type (2023-2028)
5 Global Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2017-2022)
5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022)
6.2 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2028)
6.3 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2028)
6.4 North America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022)
7.2 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2028)
7.3 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2028)
7.4 Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022)
8.2 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2028)
8.3 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2028)
8.4 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022)
9.2 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2028)
9.3 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2028)
9.4 Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022)
10.2 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2028)
10.3 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2028)
10.4 Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Products and Services
11.1.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.1.5 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.1.6 Abbott Laboratories Recent Developments
11.2 Natera, Inc
11.2.1 Natera, Inc Company Details
11.2.2 Natera, Inc Business Overview
11.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Products and Services
11.2.4 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.2.5 Natera, Inc Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.2.6 Natera, Inc Recent Developments
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Products and Services
11.3.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.3.5 PerkinElmer Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.3.6 PerkinElmer Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Products and Services
11.4.4 Illumina Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.4.5 Illumina Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.4.6 Illumina Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Products and Services
11.5.4 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.5.6 F. Hoffmann-La Roche Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Products and Services
11.6.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.6.5 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.6.6 Thermo Fisher Scientific Recent Developments
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Details
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Products and Services
11.7.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.7.5 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.7.6 Laboratory Corporation of America Holdings Recent Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Products and Services
11.8.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.8.5 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.8.6 Agilent Technologies Recent Developments
11.9 Quest Diagnostics Incorporated
11.9.1 Quest Diagnostics Incorporated Company Details
11.9.2 Quest Diagnostics Incorporated Business Overview
11.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Products and Services
11.9.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.9.5 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.9.6 Quest Diagnostics Incorporated Recent Developments
11.10 Cooper Surgical
11.10.1 Cooper Surgical Company Details
11.10.2 Cooper Surgical Business Overview
11.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Products and Services
11.10.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.10.5 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
11.10.6 Cooper Surgical Recent Developments
11.11 Beijing Genomics Institute (BGI)
11.11.1 Beijing Genomics Institute (BGI) Company Details
11.11.2 Beijing Genomics Institute (BGI) Business Overview
11.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Products and Services
11.11.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.11.5 Beijing Genomics Institute (BGI) Recent Developments
11.12 Genea Limited
11.12.1 Genea Limited Company Details
11.12.2 Genea Limited Business Overview
11.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Products and Services
11.12.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.12.5 Genea Limited Recent Developments
12 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
12.1 Preimplantation Genetics Diagnosis (PGD) Market Trends
12.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
12.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
12.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Gender Selection
Table 3. Key Players of Chromosomal Abnormalities
Table 4. Key Players of Single Gene Disorders
Table 5. Key Players of HLA Typing
Table 6. Key Players of Aneuploidy
Table 7. Key Players of X-Linked Diseases
Table 8. Key Players of Others
Table 9. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 11. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region (2017-2022)
Table 13. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players (2017-2022) & (US$ Million)
Table 14. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players (2017-2022)
Table 15. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2021)
Table 16. Ranking of Global Top Preimplantation Genetics Diagnosis (PGD) Companies by Revenue (US$ Million) in 2021
Table 17. Global 5 Largest Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue (CR5 and HHI) & (2017-2022)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
Table 20. Date of Key Manufacturers Enter into Preimplantation Genetics Diagnosis (PGD) Market
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 23. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2022)
Table 24. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 25. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2023-2028)
Table 26. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 27. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2017-2022)
Table 28. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 29. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2023-2028)
Table 30. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022) & (US$ Million)
Table 31. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2022) & (US$ Million)
Table 32. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2023-2028) & (US$ Million)
Table 33. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2022) & (US$ Million)
Table 34. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2023-2028) & (US$ Million)
Table 35. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2022) & (US$ Million)
Table 36. North America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2023-2028) & (US$ Million)
Table 37. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022) & (US$ Million)
Table 38. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2022) & (US$ Million)
Table 39. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2023-2028) & (US$ Million)
Table 40. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2022) & (US$ Million)
Table 43. Europe Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022) & (US$ Million)
Table 45. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue by Region (2023-2028) & (US$ Million)
Table 51. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022) & (US$ Million)
Table 52. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2022) & (US$ Million)
Table 53. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2023-2028) & (US$ Million)
Table 54. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2022) & (US$ Million)
Table 55. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2023-2028) & (US$ Million)
Table 56. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2022) & (US$ Million)
Table 57. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Company (2020-2022) & (US$ Million)
Table 59. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue by Country (2023-2028) & (US$ Million)
Table 65. Abbott Laboratories Company Details
Table 66. Abbott Laboratories Business Overview
Table 67. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 68. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 69. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 70. Abbott Laboratories Recent Developments
Table 71. Natera, Inc Company Details
Table 72. Natera, Inc Business Overview
Table 73. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 74. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 75. Natera, Inc Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 76. Natera, Inc Recent Developments
Table 77. PerkinElmer Company Details
Table 78. PerkinElmer Business Overview
Table 79. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 80. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 81. PerkinElmer Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 82. PerkinElmer Recent Developments
Table 83. Illumina Company Details
Table 84. Illumina Business Overview
Table 85. Illumina Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 86. Illumina Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 87. Illumina Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 88. Illumina Recent Developments
Table 89. F. Hoffmann-La Roche Company Details
Table 90. F. Hoffmann-La Roche Business Overview
Table 91. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 92. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 93. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 94. F. Hoffmann-La Roche Recent Developments
Table 95. Thermo Fisher Scientific Company Details
Table 96. Thermo Fisher Scientific Business Overview
Table 97. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 98. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 99. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 100. Thermo Fisher Scientific Recent Developments
Table 101. Laboratory Corporation of America Holdings Company Details
Table 102. Laboratory Corporation of America Holdings Business Overview
Table 103. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 104. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 105. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 106. Laboratory Corporation of America Holdings Recent Developments
Table 107. Agilent Technologies Company Details
Table 108. Agilent Technologies Business Overview
Table 109. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 110. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 111. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 112. Agilent Technologies Recent Developments
Table 113. Quest Diagnostics Incorporated Company Details
Table 114. Quest Diagnostics Incorporated Business Overview
Table 115. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 116. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 117. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 118. Quest Diagnostics Incorporated Recent Developments
Table 119. Cooper Surgical Company Details
Table 120. Cooper Surgical Business Overview
Table 121. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 122. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 123. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) SWOT Analysis
Table 124. Cooper Surgical Recent Developments
Table 125. Beijing Genomics Institute (BGI) Company Details
Table 126. Beijing Genomics Institute (BGI) Business Overview
Table 127. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 128. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 129. Beijing Genomics Institute (BGI) Recent Developments
Table 130. Genea Limited Company Details
Table 131. Genea Limited Business Overview
Table 132. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product and Services
Table 133. Genea Limited Preimplantation Genetics Diagnosis (PGD) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 134. Genea Limited Recent Developments
Table 135. Preimplantation Genetics Diagnosis (PGD) Market Trends
Table 136. Preimplantation Genetics Diagnosis (PGD) Market Drivers
Table 137. Preimplantation Genetics Diagnosis (PGD) Market Challenges
Table 138. Preimplantation Genetics Diagnosis (PGD) Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Type: 2021 VS 2028
Figure 2. Gender Selection Features
Figure 3. Chromosomal Abnormalities Features
Figure 4. Single Gene Disorders Features
Figure 5. HLA Typing Features
Figure 6. Aneuploidy Features
Figure 7. X-Linked Diseases Features
Figure 8. Others Features
Figure 9. Global Preimplantation Genetics Diagnosis (PGD) Sales Market Share by Application: 2021 VS 2028
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Preimplantation Genetics Diagnosis (PGD) Report Years Considered
Figure 14. Global Preimplantation Genetics Diagnosis (PGD) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Preimplantation Genetics Diagnosis (PGD) Market Size 2017-2028 (US$ Million)
Figure 16. Global Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Region in 2017 VS 2022
Figure 18. Global Top 10 Preimplantation Genetics Diagnosis (PGD) Countries Ranking by Market Size (US$ Million) in 2021
Figure 19. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players in 2021
Figure 20. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue in 2021
Figure 22. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Company in 2021
Figure 23. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2028)
Figure 24. North America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2017-2028)
Figure 25. North America Preimplantation Genetics Diagnosis (PGD) Revenue Share by Country (2017-2028)
Figure 26. U.S. Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 27. Canada Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 28. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Company in 2021
Figure 29. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2028)
Figure 30. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2017-2028)
Figure 31. Europe Preimplantation Genetics Diagnosis (PGD) Revenue Share by Country (2017-2028)
Figure 32. Germany Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 33. France Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 34. U.K. Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 35. Italy Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 36. Russia Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Company in 2021
Figure 38. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2028)
Figure 39. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2017-2028)
Figure 40. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Revenue Share by Region (2017-2028)
Figure 41. China Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 42. Japan Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 43. South Korea Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 44. India Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 45. Australia Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 46. Taiwan Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 47. Indonesia Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 48. Thailand Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 49. Malaysia Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 50. Philippines Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 51. Vietnam Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 52. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Company in 2021
Figure 53. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2028)
Figure 54. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2017-2028)
Figure 55. Latin America Preimplantation Genetics Diagnosis (PGD) Revenue Share by Country (2017-2028)
Figure 56. Mexico Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 57. Brazil Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 58. Argentina Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 59. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Company in 2021
Figure 60. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2028)
Figure 61. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2017-2028)
Figure 62. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Revenue Share by Country (2017-2028)
Figure 63. Turkey Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 64. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 65. U.A.E Preimplantation Genetics Diagnosis (PGD) Revenue (2017-2028) & (US$ Million)
Figure 66. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 67. Natera, Inc Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 68. PerkinElmer Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 69. Illumina Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 70. F. Hoffmann-La Roche Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 71. Thermo Fisher Scientif
  • Ultrasound Probe Disinfection Market by Product (Instrument, Services, Consumables (Disinfectants & Detergents)), Probe Type (Linear, Convex, & TEE Transducers),Process (High-Level & Low-Level Disinfection), End User (Hospitals) - Global Forecast to 2027
    Published: 17-Mar-2023        Price: US 4950 Onwards        Pages: 290
    “Global ultrasound probe disinfection market to register a CAGR of 13.3 % from 2022 to 2027” The global ultrasound probe disinfection market is projected to reach USD 936 million by 2027 from USD 501 million in 2022, at a CAGR of 13.3% during the forecast period. Growth in this market is mainly driven by the increasing incidence of hospital-acquired infections (HAIs) due to improper reprocessing of ultrasound probes, and government regulations and guidelin......
  • Global Mrsa Testing Devices Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 109
    The Mrsa Testing Devices market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Mrsa Testing Devices industry, and breaks down according to the type, application, and consumption area of Mrsa Testing Devices. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and descr......
  • Global Coronary Guidewires Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 100
    The Coronary Guidewires market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Coronary Guidewires industry, and breaks down according to the type, application, and consumption area of Coronary Guidewires. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Global Lateral Flow POC Reader Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 123
    The Lateral Flow POC Reader market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Lateral Flow POC Reader industry, and breaks down according to the type, application, and consumption area of Lateral Flow POC Reader. The report also introduces players in the industry from the perspective of the industry chain and marketing chain ......
  • Global Infrared Thermometer Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 103
    The Infrared Thermometer market revenue was 2567.96 Million USD in 2022, and will reach 4096.2 Million USD in 2028, with a CAGR of 8.09% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Infrared Thermometer industry, and breaks down according to the type, application, and consumption area of Infrared Thermometer. The report also introduces players in the industry from the perspective of the industry chain and marketing chai......
  • Global Infertility Treatment Devices Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Infertility Treatment Devices market revenue was 399.39 Million USD in 2022, and will reach 662.62 Million USD in 2028, with a CAGR of 8.8% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Infertility Treatment Devices industry, and breaks down according to the type, application, and consumption area of Infertility Treatment Devices. The report also introduces players in the industry from the perspective of the industry......
  • Global Endoscopy Visualization System Components Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 117
    The Endoscopy Visualization System Components market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Endoscopy Visualization System Components industry, and breaks down according to the type, application, and consumption area of Endoscopy Visualization System Components. The report also introduces players in the industry from the ......
  • Global Medical Kits And Trays Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 129
    The Medical Kits And Trays market revenue was 12355.6 Million USD in 2022, and will reach 19215.54 Million USD in 2028, with a CAGR of 7.64% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Medical Kits And Trays industry, and breaks down according to the type, application, and consumption area of Medical Kits And Trays. The report also introduces players in the industry from the perspective of the industry chain and market......
  • Global Elastic Therapeutic Tape Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 120
    The Elastic therapeutic tape is an elastic cotton strip with an acrylic adhesive that is used with the intent of treating pain and disability from athletic injuries and a variety of other physical disorders. The Elastic Therapeutic Tape market revenue was 264.16 Million USD in 2022, and will reach 511.88 Million USD in 2028, with a CAGR of 11.66% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Elastic Therapeutic Ta......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs